900 WEST PLATT STREET, SUITE 200, TAMPA, FL
Other Events
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1
Q2
Q1
FY 2023
Q3
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Registration of Securities
Amended Registration Statement for Securities
No filings found
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Prospectus Filed Pursuant to Rule 424(b)(1)
Correspondence
Submission Upload